Aeglea BioTherapeutics, Inc. Profile Avatar - Palmy Investing

Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recomb…

Biotechnology
US, Austin [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of AGLE's Analysis
CIK: 1636282 CUSIP: 00773J103 ISIN: US00773J2024 LEI: - UEI: -
Secondary Listings
AGLE has no secondary listings inside our databases.